{
  "report_rows": [
    {
      "kpi": "Q2 2026 Revenue",
      "prediction": "BEAT",
      "answer": "pred ~$895M vs. cons $883M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 Adjusted EBITDA",
      "prediction": "BEAT",
      "answer": "pred ~$225M vs. cons $221M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 Non-GAAP Diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.86 vs. cons $1.79",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY 2026 Revenue Guidance",
      "prediction": "BETTER",
      "answer": "guide ~$3.64B-$3.70B vs. cons $3.67B (FY 2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY 2026 Adjusted EBITDA Margin Guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~25.5% vs. cons 25.5% (FY 2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY 2026 Free Cash Flow Guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$450M vs. cons $455M (FY 2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 2.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 4.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "Revenue and EBITDA beats of ~$12M and ~$4M, respectively, paired with a FY revenue-guide upper-end increase to ~$3.70B versus ~$3.67B consensus, should support modest positive FY and 2027 estimate revisions despite unchanged ~25.5% EBITDA-margin guidance and continued mix pressure.",
  "day5_confidence": "MEDIUM"
}